Federica Papaccio

2.9k total citations
42 papers, 2.0k citations indexed

About

Federica Papaccio is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Federica Papaccio has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Federica Papaccio's work include Cancer Cells and Metastasis (9 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer-related Molecular Pathways (7 papers). Federica Papaccio is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer-related Molecular Pathways (7 papers). Federica Papaccio collaborates with scholars based in Italy, Spain and United Kingdom. Federica Papaccio's co-authors include Virginia Tirino, Gianpaolo Papaccio, Vincenzo Desiderio, Francesca Paino, Tarik Regad, Marcella La Noce, Alfredo De Rosa, Fortunato Ciardiello, Floriana Morgillo and Francesco De Francesco and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Federica Papaccio

41 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Federica Papaccio Italy	21	1.0k	909	594	293	185	42	2.0k
Go J. Yoshida Japan	21	1.5k 1.5×	931 1.0×	949 1.6×	313 1.1×	248 1.3×	25	2.5k
Li Ren Kong China	23	887 0.9×	646 0.7×	476 0.8×	501 1.7×	224 1.2×	77	2.0k
Rong Shao China	21	981 1.0×	730 0.8×	463 0.8×	255 0.9×	206 1.1×	58	2.3k
Yong Xu China	26	1.1k 1.1×	461 0.5×	631 1.1×	404 1.4×	142 0.8×	83	2.1k
Sean Yoder United States	19	876 0.9×	728 0.8×	362 0.6×	241 0.8×	251 1.4×	62	1.8k
JiHoon Kang South Korea	21	642 0.6×	493 0.5×	476 0.8×	275 0.9×	100 0.5×	63	1.4k
Wenting Xu China	18	872 0.9×	424 0.5×	412 0.7×	206 0.7×	168 0.9×	46	1.6k
Jason R. Pitarresi United States	15	959 1.0×	830 0.9×	467 0.8×	256 0.9×	358 1.9×	36	1.8k
Niranjan Awasthi United States	25	889 0.9×	703 0.8×	338 0.6×	294 1.0×	231 1.2×	65	1.9k
Eduardo Farias United States	29	1.4k 1.4×	774 0.9×	618 1.0×	212 0.7×	425 2.3×	67	2.7k

Countries citing papers authored by Federica Papaccio

Since Specialization

Citations

This map shows the geographic impact of Federica Papaccio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Papaccio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Papaccio more than expected).

Fields of papers citing papers by Federica Papaccio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Papaccio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Papaccio. The network helps show where Federica Papaccio may publish in the future.

Co-authorship network of co-authors of Federica Papaccio

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Papaccio. A scholar is included among the top collaborators of Federica Papaccio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Papaccio. Federica Papaccio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Papaccio, Federica, Manuel Cabeza-Segura, Francisco Gimeno-Valiente, et al.. (2025). Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids. Journal of Experimental & Clinical Cancer Research. 44(1). 77–77. 4 indexed citations

Greppi, Marco, Valentina Obino, Davide Frumento, et al.. (2024). NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances. Immunology Letters. 270. 106932–106932. 12 indexed citations

Omodei, Daniela, Caterina De Rosa, Roberta Buono, et al.. (2024). Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer. Cancers. 16(23). 3941–3941. 1 indexed citations

Russo, Filomena, Feliciana Mariotti, Federica Papaccio, et al.. (2024). The possible and intriguing relationship between bullous pemphigoid and melanoma: speculations on significance and clinical relevance. Frontiers in Immunology. 15. 4 indexed citations

Rosa, Caterina De, Viviana De Rosa, Concetta Tuccillo, et al.. (2024). ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC. Scientific Reports. 14(1). 500–500. 9 indexed citations

Cabeza-Segura, Manuel, Marcella La Noce, Valeria Conti, et al.. (2023). How organoids can improve personalized treatment in patients with gastro-esophageal tumors. Current Opinion in Pharmacology. 69. 102348–102348. 8 indexed citations

Bocchetti, Marco, Silvia Zappavigna, Sarah Wagner, et al.. (2022). MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 20–20. 43 indexed citations

Bravo, Miren, Federica Papaccio, Carolina Martínez‐Ciarpaglini, et al.. (2020). 488P Patient-derived organoids as a tool for modelling localized colorectal cancer. Annals of Oncology. 31. S448–S448. 2 indexed citations

D’Abrosca, Brigida, Vincenza Ciaramella, Vittoria Graziani, et al.. (2019). Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis. Scientific Reports. 9(1). 4986–4986. 24 indexed citations

10.

Mele, Luigi, Marcella La Noce, Francesca Paino, et al.. (2019). Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation. Journal of Experimental & Clinical Cancer Research. 38(1). 160–160. 91 indexed citations

11.

Noce, Marcella La, Francesca Paino, Luigi Mele, et al.. (2018). HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy. Journal of Experimental & Clinical Cancer Research. 37(1). 296–296. 62 indexed citations

12.

Roselló, Susana, Federica Papaccio, Desamparados Roda, Noelia Tarazona, & Andrés Cervantes. (2018). The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision. Cancer Treatment Reviews. 63. 156–171. 33 indexed citations

13.

Bruixola, G., Javier Caballero‐Villarraso, Federica Papaccio, et al.. (2018). Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer. ESMO Open. 3(6). e000425–e000425. 50 indexed citations

14.

Mele, Luigi, Francesca Paino, Federica Papaccio, et al.. (2018). A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo. Cell Death and Disease. 9(5). 572–572. 160 indexed citations

15.

Corte, Carminia Maria Della, Giuseppe Viscardi, Federica Papaccio, et al.. (2017). Implication of the Hedgehog pathway in hepatocellular carcinoma. World Journal of Gastroenterology. 23(24). 4330–4330. 62 indexed citations

16.

Morgillo, Floriana, Morena Fasano, Carminia Maria Della Corte, et al.. (2017). Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer. ESMO Open. 2(2). e000132–e000132. 68 indexed citations

17.

Barra, Giusi, G Ghilardi, Carminia Maria Della Corte, et al.. (2016). Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy. Annals of Oncology. 27. vi364–vi364. 1 indexed citations

18.

Corte, Carminia Maria Della, Claudio Bellevicine, Giovanni Vicidomini, et al.. (2015). SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer. Clinical Cancer Research. 21(20). 4686–4697. 97 indexed citations

19.

Fasano, Morena, Carminia Maria Della Corte, Annalisa Capuano, et al.. (2014). A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non–Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial. Clinical Lung Cancer. 16(1). 57–59. 16 indexed citations

20.

Tirino, Virginia, Vincenzo Desiderio, Francesca Paino, et al.. (2012). Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. The FASEB Journal. 27(1). 13–24. 322 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact